Colony formation assays demonstrated that an acute knock out of PRMT1 or PRMT5 significantly increased the sensitivity levels of cancer cells to PARPi treatment, thereby phenocopying the results obtained using chemical PRMT inhibitors (Figure 2I and 2J). Here, PRMT1 is linked to cancer.